476 related articles for article (PubMed ID: 17308079)
21. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
22. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
25. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
[TBL] [Abstract][Full Text] [Related]
26. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells.
Sinkkonen L; Hugenschmidt T; Berninger P; Gaidatzis D; Mohn F; Artus-Revel CG; Zavolan M; Svoboda P; Filipowicz W
Nat Struct Mol Biol; 2008 Mar; 15(3):259-67. PubMed ID: 18311153
[TBL] [Abstract][Full Text] [Related]
28. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
29. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
[TBL] [Abstract][Full Text] [Related]
30. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
Chen KC; Wang YS; Hu CY; Chang WC; Liao YC; Dai CY; Juo SH
FASEB J; 2011 May; 25(5):1718-28. PubMed ID: 21266537
[TBL] [Abstract][Full Text] [Related]
31. The role of epigenetic transcription repression and DNA methyltransferases in cancer.
Daniel FI; Cherubini K; Yurgel LS; de Figueiredo MA; Salum FG
Cancer; 2011 Feb; 117(4):677-87. PubMed ID: 20945317
[TBL] [Abstract][Full Text] [Related]
32. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1.
Ting AH; Jair KW; Suzuki H; Yen RW; Baylin SB; Schuebel KE
Nat Genet; 2004 Jun; 36(6):582-4. PubMed ID: 15156141
[TBL] [Abstract][Full Text] [Related]
33. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide epigenetic regulation of miRNAs in cancer.
Baer C; Claus R; Plass C
Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
[TBL] [Abstract][Full Text] [Related]
35. Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.
Iliou MS; Lujambio A; Portela A; Brüstle O; Koch P; Andersson-Vincent PH; Sundström E; Hovatta O; Esteller M
Epigenetics; 2011 Nov; 6(11):1344-53. PubMed ID: 22048248
[TBL] [Abstract][Full Text] [Related]
36. A microRNA DNA methylation signature for human cancer metastasis.
Lujambio A; Calin GA; Villanueva A; Ropero S; Sánchez-Céspedes M; Blanco D; Montuenga LM; Rossi S; Nicoloso MS; Faller WJ; Gallagher WM; Eccles SA; Croce CM; Esteller M
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13556-61. PubMed ID: 18768788
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.
Lee KH; Lotterman C; Karikari C; Omura N; Feldmann G; Habbe N; Goggins MG; Mendell JT; Maitra A
Pancreatology; 2009; 9(3):293-301. PubMed ID: 19407485
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation of microRNA genes in multiple myeloma.
Wong KY; Huang X; Chim CS
Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
[TBL] [Abstract][Full Text] [Related]
39. CpG island hypermethylation of tumor suppressor microRNAs in human cancer.
Lujambio A; Esteller M
Cell Cycle; 2007 Jun; 6(12):1455-9. PubMed ID: 17581274
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer.
Lopez-Serra P; Esteller M
Oncogene; 2012 Mar; 31(13):1609-22. PubMed ID: 21860412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
